^
Association details:
Biomarker:No biomarker
Cancer:Mantle Cell Lymphoma
Regimen:R-DHAX (cytarabine + dexamethasone injection + oxaliplatin + Rituxan (rituximab))
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
01/20/2021
Excerpt:
Mantle Cell Lymphoma: INDUCTION THERAPY…Preferred Regimens…RDHA (rituximab, dexamethasone, cytarabine) + platinum (carboplatin, cisplatin, or oxaliplatin)